Invesco Dynamic Retail Company Name:
PMR Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants - The final results of the APLICOV-PC study (Phase I-II), which were initially released last May ...
- Lurbinectedin is approved under "Accelerated Approval" based on overall response rate and duration of response demonstrated in an open-label, monotherapy clinical trial. - The anti-tumor compound lurbinectedin will be marketed under the brand name Zepzelca ™ . - Lurbinected...
- The objective of the trial is to evaluate the efficacy and safety of plitidepsin in patients with COVID-19 requiring hospital admission - Plitidepsin recently obtained positive results from in vitro studies on the human HCoV-229E coronavirus, carried out at the National Biotech...